<div id="readability-page-1"><div> <div> , /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde &amp; Associates PC (the &#34;M&amp;A Class Action Firm&#34;), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2025 ISS Securities Class Action Services Report. The firm is headquartered at the Empire State Building in New York City and is investigating Bio-Techne Corporation (NASDAQ: TECH) related to its sale to Merck KGaA. Under the terms of the proposed transaction, Bio-Techne shareholders are expected to receive $73.00 per share in cash. Is it a fair deal? Click here for more info https://monteverdelaw.com/case/bio-techne-corporation/. It is free and there is no cost or obligation to you. NOT ALL LAW FIRMS ARE EQUAL. Before you hire a law firm, you should talk to a lawyer and ask: <ol type="1"> <li>Do you file class actions and go to Court?</li> <li>When was the last time you recovered money for shareholders?</li> <li>What cases did you recover money in and how much?</li> </ol> About Monteverde &amp; Associates PC Our firm litigates and has recovered money for shareholders…and we do it from our offices in the Empire State Building. We are a national class action securities firm with a successful track record in trial and appellate courts, including the U.S. Supreme Court. No one is above the law. If you own common stock in the above listed company and have concerns or wish to obtain additional information free of charge, please visit our website or contact Juan Monteverde, Esq. either via e-mail at [email protected] or by telephone at (212) 971-1341. Contact: Juan Monteverde, Esq. MONTEVERDE &amp; ASSOCIATES PC The Empire State Building 350 Fifth Ave. Suite 4740 New York, NY 10118 United States of America [email protected] Tel: (212) 971-1341 Attorney Advertising. (C) 2026 Monteverde &amp; Associates PC. The law firm responsible for this advertisement is Monteverde &amp; Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter. SOURCE Monteverde &amp; Associates PC <img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNjI2Jk5ld3NJdGVtSWQ9REM5MzMwNCZUcmFuc21pc3Npb25fSWQ9MjAyNjA2MjYxNDI0UFJfTkVXU19VU1BSX19fX19EQzkzMzA0?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNjI2Jk5ld3NJdGVtSWQ9REM5MzMwNCZUcmFuc21pc3Npb25fSWQ9MjAyNjA2MjYxNDI0UFJfTkVXU19VU1BSX19fX19EQzkzMzA0"/></div> </div></div>

TECH

Monteverde & Associates PC, a class action law firm, has announced an investigation into Bio-Techne Corporation (NASDAQ: TECH) regarding its proposed sale to Merck KGaA. Under the deal terms, shareholders are set to receive $73.00 per share in cash. The firm is assessing whether this transaction constitutes a fair deal for investors.

14:24 ETSHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Bio-Techne Corporation (NASDAQ: TECH)